These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27388553)

  • 21. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
    Lonardo A; Ballestri S; Marchesini G; Angulo P; Loria P
    Dig Liver Dis; 2015 Mar; 47(3):181-90. PubMed ID: 25739820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
    Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
    Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic Fatty Liver Disease.
    Filipović B; Forbes A; Tepeš B; Dumitraşcu DL
    Can J Gastroenterol Hepatol; 2018; 2018():2097435. PubMed ID: 30155450
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling.
    Chhatwal J; Tapper EB
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):280-282. PubMed ID: 35123079
    [No Abstract]   [Full Text] [Related]  

  • 26. Incidence of chronic kidney disease in patients with non-alcoholic fatty liver disease.
    Zou ZY; Fan JG
    J Hepatol; 2020 Jul; 73(1):214-216. PubMed ID: 32229037
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
    Luo J; Xu L; Li J; Zhao S
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.
    ; Lonardo A; Bellentani S; Argo CK; Ballestri S; Byrne CD; Caldwell SH; Cortez-Pinto H; Grieco A; Machado MV; Miele L; Targher G
    Dig Liver Dis; 2015 Dec; 47(12):997-1006. PubMed ID: 26454786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease.
    Patel V; Sanyal AJ; Sterling R
    Clin Liver Dis; 2016 May; 20(2):277-92. PubMed ID: 27063269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
    Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
    Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current Status and Future Prospects of Nonalcoholic Fatty Liver Disease (NAFLD) in Japan-Feedback from Clinical and Basic Researches to Medical Therapy and Pharmacist Activities].
    Tokuyama S; Kim KI
    Yakugaku Zasshi; 2016; 136(4):563. PubMed ID: 27040339
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
    Mantovani A; Gisondi P; Lonardo A; Targher G
    Int J Mol Sci; 2016 Feb; 17(2):217. PubMed ID: 26861300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease as a multi-systemic disease.
    Fotbolcu H; Zorlu E
    World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fibrosis markers of nonalcoholic steatohepatitis.
    Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
    World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes.
    Lonardo A; Byrne CD; Caldwell SH; Cortez-Pinto H; Targher G
    Hepatology; 2016 Oct; 64(4):1388-9. PubMed ID: 27038241
    [No Abstract]   [Full Text] [Related]  

  • 38. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease - a growing public health problem.
    Mikolašević I; Filipec Kanižaj T; Targher G
    Croat Med J; 2021 Feb; 62(1):1-3. PubMed ID: 33660954
    [No Abstract]   [Full Text] [Related]  

  • 40. A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.
    Temple JL; Cordero P; Li J; Nguyen V; Oben JA
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.